June 19, 2020

MTB Webinar Objectives


At the conclusion of the activity, participants will be able to:

  • Evaluate clinical data regarding the use of biomarkers in qualifying patients for specific oncolytic therapies
  • Interpret tumor pathology reports to facilitate evidence-based treatment across malignancies
  • Summarize diagnostic and treatment-related data relevant to multidisciplinary care
  • Evaluate the most relevant data regarding the current and evolving role of genomic assays in cancer management.